Search the LJMU website

Search results filters

1. Interview with visiting law professor, Sarah Buhler

   Rachel Stalker, Senior Lecturer in Law and founder of the pro bono Legal Advice Centre at LJMU, recently hosted University of Saskatchewan law professor Sarah Buhler.

2. Amy Cunningham Start-up Case Study | Student Futures

   Amy Cunningham graduated in 2023 with a degree in Marketing and now runs her own marketing business called The Social Muze.

3. My University Clearing story – Alex, Business Management (BSc)

   We hear from Alex - a fourth year Business Management (BSc) student at LJMU about her experience with Clearing

4. Studying MSc Sport and Clinical Biomechanics at LJMU

   From practical labs to career-shaping opportunities, MSc student Briony shares what it’s really like to study Sport and Clinical Biomechanics at LJMU.

5. Talyn Hushon Graduate Scheme Case Study | Student Futures

   Talyn Hushon graduated with a degree in History in July 2025 and has secured a place on the Impact Local Government Graduate Scheme as a Graduate Management Trainee.

6. Clearing – How to get a Clearing offer

   Received your results and they’re not what you expected? Changed your mind about your choice of course? Decided you want to live at home or move somewhere else?

7. Mollie's Clearing blog

   We sit down with Mollie who applied to LJMU on Results Day to find out what applying through Clearing is like.

8. Top tips on looking after your mental health during your time at university

   Starting university is a big step and although exciting, it can be a challenge for anyone’s mental wellbeing. Wendy Lavin, LJMU Student Wellbeing Team Leader, is giving her top tips on looking after your mental health during your time at university.

9. Mark Smith Graduate Case Study | Student Futures

   Mark Smith is a Biology graduate who works for Eurofins Forensics Services as a Forensic DNA Analyst.

10. Prescription drugs pregabalin and gabapentin have been reclassified – but it won’t stop problem use

    Prescription drugs pregabalin and gabapentin have been reclassified – but it won’t stop problem use